Secreted glucocorticoids regulate leukocyte-endothelial interactions in inflammation. A direct vital microscopic study.
Leukocytes come into intimate contact with the venular endothelium as they extravasate from blood to the interstitium during inflammation. In exteriorized tissues, the number of leukocytes rolling along the vessel wall was markedly increased in adrenalectomized and metyrapone-treated animals, relative to sham-operated and normal animals. During the development of an acute, local inflammatory response, rollers were numerically decreased and a stronger adhesion of the cells to the endothelium, with a concomitant migration into tissues, was observed. Adhesion and migration were much more marked in adrenalectomized and metyrapone-treated animals than in controls, suggesting that secreted glucocorticoids exert a suppressive effect on leukocyte-endothelial interactions. The increased number of rolling leukocytes in adrenalectomized and metyrapone-treated animals apparently resulted in more cells available to migrate into inflamed tissues. The effect appears to involve receptor occupancy and induction of gene expression because normal animals receiving the steroid antagonist RU 38 486, actinomycin D, or cycloheximide behaved as adrenalectomized or metyrapone-treated animals. Administration to adrenalectomized animals of a monoclonal antibody to the membrane glycoprotein complex CD18 did not affect the number of rolling cells, but dramatically reduced the number of adherent or migrated leukocytes. It is suggested that secreted glucocorticoids, in addition to an effect on rolling behavior of circulating leukocytes, might also modulate the activity of the glycoprotein complex CD18 on white blood cells. The ultimate consequence is a restrictive effect on cell emigration in inflammation.
Farsky
S P
SP
Department of Pharmacology, University of São Paulo, Brazil.
Sannomiya
P
P
Garcia-Leme
J
J
D000315:Adrenalectomy; D000818:Animals; D018821:CD18 Antigens / Q000502:physiology; D002448:Cell Adhesion; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004730:Endothelium, Vascular / Q000473:pathology*; D005938:Glucocorticoids / Q000502:physiology*; D007158:Immunologic Techniques; D007249:Inflammation / Q000473:pathology*; D008297:Male; D008797:Metyrapone / Q000494:pharmacology; D008833:Microcirculation; D015735:Mifepristone / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D012039:Regional Blood Flow
D018821:CD18 Antigens; D005938:Glucocorticoids; D003609:Dactinomycin; D015735:Mifepristone; D003513:Cycloheximide; D008797:Metyrapone